Lv1
20 积分 2025-05-08 加入
The global burden of lung cancer: current status and future trends
1个月前
已完结
Efficacy of PD-1/PDL-1 inhibitors for ovarian cancer: a systematic review and network meta-analysis
1个月前
已完结
The global burden of lung cancer: current status and future trends
1个月前
已完结
Cancer statistics for the year 2020: An overview
2个月前
已完结
Epithelial ovarian cancer
4个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
4个月前
已完结
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
4个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
4个月前
已完结
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies
4个月前
已完结
Albumin-bound paclitaxel plus anlotinib in patients with recurrent, platinum-resistant primary epithelial ovarian cancer (A-Plus): a phase II, single-arm, prospective study
4个月前
已完结
皖公网安备34019202002308
